Mast cells predict hypersensitive reactions in rituximab desensitization

HOUSTON – For rituximab patients undergoing desensitization, mast cell degranulation is a more effective predictor of hypersensitive reactions (HSR) than are the traditionally employed skin tests, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma, and...
Source: Skin and Allergy News - Category: Dermatology Tags: FPN News FPN Allergy & Immunology FPN Rheumatology IMN News IMN Allergy IMN Rheumatology RHEUM News Source Type: news